| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 153.82M | 164.48M | 142.81M | 150.36M | 152.02M | 126.06M |
| Gross Profit | 36.35M | 34.43M | 31.69M | 33.26M | 40.08M | 40.17M |
| EBITDA | 604.82K | -3.20M | -590.87K | 1.99M | 8.60M | 9.00M |
| Net Income | -1.23M | -7.05M | -2.33M | 192.53K | 4.46M | 6.82M |
Balance Sheet | ||||||
| Total Assets | 119.42M | 118.11M | 110.03M | 95.32M | 101.88M | 82.73M |
| Cash, Cash Equivalents and Short-Term Investments | 37.27M | 29.07M | 31.22M | 22.21M | 18.40M | 28.90M |
| Total Debt | 31.65M | 33.87M | 26.23M | 11.37M | 14.47M | 7.55M |
| Total Liabilities | 56.76M | 60.52M | 46.11M | 29.81M | 34.08M | 25.00M |
| Stockholders Equity | 60.69M | 55.54M | 62.51M | 64.58M | 66.55M | 56.69M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.80M | 6.81M | 9.19M | -17.55M | -3.68M |
| Operating Cash Flow | -4.17M | -2.54M | 8.93M | 9.71M | 3.20M | -2.61M |
| Investing Cash Flow | -15.45M | -1.75M | -12.25M | -306.05K | -16.29M | -6.08M |
| Financing Cash Flow | 7.89M | 2.90M | 10.19M | -4.32M | 7.47M | 19.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $36.05M | -88.00 | -2.06% | ― | 3.24% | -115.15% | |
59 Neutral | $48.37M | -20.02 | -17.37% | ― | 9.62% | 26.59% | |
56 Neutral | $32.69M | -28.21 | -0.97% | ― | -20.20% | -799.54% | |
51 Neutral | $34.80M | -4.40 | -11.94% | ― | 15.17% | -172.09% | |
44 Neutral | $7.33M | -0.11 | -184.82% | ― | ― | -81.60% |
The board authorized a share repurchase program announced on February 4, 2026, allowing CLPS to buy back up to 1,000,000 common shares when the price falls below US$2.00 between February 5 and November 4, 2026, aiming to enhance market value and protect long-term shareholder interests through opportunistic open-market or negotiated transactions, although the company can suspend or end purchases at will depending on market conditions.
The most recent analyst rating on (CLPS) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Clps stock, see the CLPS Stock Forecast page.